|
FAM55C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.61240000427088E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.91256999999556E-05 |
| Normal-vs-Stage2 |
1.41220000027253E-07 |
| Normal-vs-Stage3 |
1.02970000004365E-06 |
| Normal-vs-Stage4 |
7.23989979078965E-10 |
| Stage1-vs-Stage2 |
7.656300E-02 |
| Stage1-vs-Stage3 |
1.890360E-01 |
| Stage1-vs-Stage4 |
8.996100E-04 |
| Stage2-vs-Stage3 |
4.730800E-01 |
| Stage2-vs-Stage4 |
3.074800E-01 |
| Stage3-vs-Stage4 |
7.536200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.34790000061847E-08 |
| Normal-vs-AfricanAmerican |
1.161150E-03 |
| Normal-vs-Asian |
3.248200E-04 |
| Caucasian-vs-AfricanAmerican |
4.699400E-01 |
| Caucasian-vs-Asian |
5.659400E-01 |
| AfricanAmerican-vs-Asian |
9.248800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.77630000047979E-07 |
| Normal-vs-Female |
2.71150000008546E-07 |
| Male-vs-Female |
3.850200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.195490E-04 |
| Normal-vs-Age(41-60Yrs) |
2.39140000024562E-08 |
| Normal-vs-Age(61-80Yrs) |
1.02380000033264E-07 |
| Normal-vs-Age(81-100Yrs) |
8.397500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.569700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.013580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.674000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.045800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.467400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.015800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.190030E-01 |
| Classical-VS-Follicular |
6.572800E-01 |
| Classical-VS-Other |
1.369650E-01 |
| Classical-VS-Normal |
1.01019999998453E-06 |
| Tall-VS-Follicular |
2.295000E-01 |
| Tall-VS-Other |
4.604400E-01 |
| Tall-VS-Normal |
1.36959999996744E-06 |
| Follicular-VS-Other |
2.534200E-01 |
| Follicular-VS-Normal |
5.99489999999481E-05 |
| Other-VS-Normal |
5.963900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.74779999993081E-07 |
| Normal-vs-N1 |
1.21190000257343E-08 |
| N0-vs-N1 |
9.444200E-02 |
|
|
